Improving person-centred care for people with dementia in care homes

An optimised person-centred intervention to improve mental health and reduce anti-psychotics amongst people with dementia in care homes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN40313497

Enrollment

Registered

2011-05-10

Start date

2011-08-03

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Mental and Behavioural Disorders Dementia

Interventions

Evaluations will be undertaken to understand the breadth of benefits conferred by three key interventions to be assessed when used in addition to the person-centred care (PCC) training package, whose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 21/01/2013: All individuals residing in participating care homes who score ?1? or greater on the CDR and score ?4? or greater on the FAST in the 16 participating care facilities will be eligible to participate. Previous inclusion criteria until 21/01/2013: All individuals (aged 40 - 120 years, either sex) with dementia residing [ Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM IV) criteria, FAST staging] in the 16 participating care facilities will be eligible to participate

Exclusion criteria

Exclusion criteria: Absence of dementia. Data will not be collected from individuals for whom consent has not been obtained.

Design outcomes

Primary

Measure	Time frame
1. Antipsychotic use (number and proportion of people and dose) - measured at baseline and post intervention using records search and drug chart 2. Agitation - measured at baseline and post intervention using the Cohen-Mansfield Agitation Inventory	—

Secondary

Measure	Time frame
1. Use of psychotropic drugs (number and proportion of people and dose) - measured at baseline and post intervention using records search and drug chart 2. Other (not including agitation) behavioural and neuropsychiatric symptoms including apathy and psychosis - measured at baseline and post intervention using the NeuroPsychiatric Inventory - Nursing Home version (NPI NH) 3. Mood - measured at baseline and post intervention using the Cornell Depression Scale 4. Unmet Needs - measured at baseline and post intervention using theCamberwell Assessment of Need in the Elderly (CANE) 5. Quality of Life - measured at baseline and post intervention using a measure of health-related quality of life for people with dementia (DEMQOL) and Quality Of Life in Alzheimer's Disease (QoL AD) 6. Quality of interactions between staff and residents - measured at baseline and post intervention using the Quality of Interaction Scale (QUIS) 7. Falls - measured on an on-going basis using falls records	—

Measure

Time frame

1. Use of psychotropic drugs (number and proportion of people and dose) - measured at baseline and post intervention using records search and drug chart 2. Other (not including agitation) behavioural and neuropsychiatric symptoms including apathy and psychosis - measured at baseline and post intervention using the NeuroPsychiatric Inventory - Nursing Home version (NPI NH) 3. Mood - measured at baseline and post intervention using the Cornell Depression Scale 4. Unmet Needs - measured at baseline and post intervention using theCamberwell Assessment of Need in the Elderly (CANE) 5. Quality of Life - measured at baseline and post intervention using a measure of health-related quality of life for people with dementia (DEMQOL) and Quality Of Life in Alzheimer's Disease (QoL AD) 6. Quality of interactions between staff and residents - measured at baseline and post intervention using the Quality of Interaction Scale (QUIS) 7. Falls - measured on an on-going basis using falls records

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 24, 2026